Published July 13, 1993
| Version v1
Patent
Radiopharmaceutical bacteriostats
Creators
Description
A radiopharmaceutical has been prepared with a composition comprising: (a) a radioactive iodine-based radiopharmaceutical; (b) an auto radiolytic decomposition-inhibiting antioxidant selected from: (i) ascorbic acid (ii) nicotinamide, (iii) nicotinic acid, and (iv) a mixture of ascorbic acid and nicotinamide; (c) a bacteriostat selected from: (i) benzalkonium chloride, and (ii) benzethonium chloride
Availability note (English)
Patent and Trademark Office, Box 9, Washington, DC 20232 (United States).Additional details
Publishing Information
- Imprint Pagination
- [10 p.].
- IPC:
- Int. Cl. A61K 49/02; A61K 43/00.
- IPC
- Int. Cl. A61K 49/02; A61K 43/00.
- Patent number
- US patent document 5,227,152/A/
INIS
- Country of Publication
- United States
- Country of Input or Organization
- United States
- INIS RN
- 24069621
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Resource subtype / Literary indicator
- Non-conventional Literature
- Descriptors DEI
- ANTIBIOTICS; ANTIOXIDANTS; CHEMICAL COMPOSITION; CHEMICAL PREPARATION; IODINE ISOTOPES; RADIOPHARMACEUTICALS
- Descriptors DEC
- ANTI-INFECTIVE AGENTS; DRUGS; LABELLED COMPOUNDS; MATERIALS; ORGANIC COMPOUNDS; RADIOACTIVE MATERIALS; SYNTHESIS
Optional Information
- Secondary number(s)
- US patent application 7-806,572.